Email this article 
Hide
Show all
Lessons from the Field
Implementation of broad screening with Ebola rapid diagnostic tests in Forécariah, Guinea
Submitted: 04 May 2016 | Published: 31 March 2017
About the author(s)
Frantz Jean Louis, Centers for Disease Control and Prevention, Port-au-Prince, HaitiJennifer Y. Huang, Centers for Diseases Control and Prevention, Atlanta, Georgia, United States
Yacouba K. Nebie, World Health Organization, Conakry, Guinea
Lamine Koivogui, Institut National de Sante Publique, Conakry, Guinea
Gayatri Jayaraman, World Health Organization, Conakry, Guinea
Nadine Abiola, Centers for Diseases Control and Prevention, Kinshasa, Congo
Amanda Vansteelandt, Centers for Diseases Control and Prevention, Atlanta, Georgia, United States
Mary C. Worrel, Centers for Diseases Control and Prevention, Atlanta, Georgia, United States
Judith Shang, Centers for Diseases Control and Prevention, Yaoundé, Cameroon
Louise B. Murphy, Centers for Diseases Control and Prevention, Atlanta, Georgia, United States
David L. Fitter, Centers for Diseases Control and Prevention, Atlanta, Georgia, United States
Barbara J. Marston, Centers for Diseases Control and Prevention, Atlanta, Georgia, United States
Lise Martel, Centers for Diseases Control and Prevention, Conakry, Guinea
Abstract
Background: Laboratory-enhanced surveillance is critical for rapidly detecting the potential re-emergence of Ebola virus disease. Rapid diagnostic tests (RDT) for Ebola antigens could expand diagnostic capacity for Ebola virus disease.
Objectives: The Guinean National Coordination for Ebola Response conducted a pilot implementation to determine the feasibility of broad screening of patients and corpses with the OraQuick® Ebola RDT.
Methods: The implementation team developed protocols and trained healthcare workers to screen patients and corpses in Forécariah prefecture, Guinea, from 15 October to 30 November 2015. Data collected included number of consultations, number of fevers reported or measured, number of tests performed for patients or corpses and results of confirmatory RT-PCR testing. Data on malaria RDT results were collected for comparison. Feedback from Ebola RDT users was collected informally during supervision visits and forums.
Results: There were 3738 consultations at the 15 selected healthcare facilities; 74.6% of consultations were for febrile illness. Among 2787 eligible febrile patients, 2633 were tested for malaria and 1628 OraQuick® Ebola RDTs were performed. A total of 322 OraQuick® Ebola RDTs were conducted on corpses. All Ebola tests on eligible patients were negative.
Conclusions: Access to Ebola testing was expanded by the implementation of RDTs in an emergency situation. Feedback from Ebola RDT users and lessons learned will contribute to improving quality for RDT expansion.
Keywords
Metrics
Total abstract views: 6418Total article views: 8902
Crossref Citations
1.
The Use of Near-Infrared Light-Emitting Fluorescent Nanodiamond Particles to Detect Ebola Virus Glycoprotein: Technology Development and Proof of Principle
Giora Z Feuerstein, Michael A Mansfield, Peter I Lelkes, Salvatore Alesci, Cezary Marcinkiewicz, Nathan Butlin, Mark Sternberg
International Journal of Nanomedicine vol: Volume 15 first page: 7583 year: 2020
doi: 10.2147/IJN.S261952
2. Strengthening Outbreak Detection in Africa to Achieve the 7-1-7 Global Framework: Challenges and Opportunities
Frantz Jean Louis, Lisa Nichols, Cristina de la Torre, Anicet G. Dahourou
Public Health Reviews vol: 46 year: 2025
doi: 10.3389/phrs.2025.1608039
3. Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks
M. Jeremiah Matson, Daniel S. Chertow, Vincent J. Munster
Emerging Microbes & Infections vol: 9 issue: 1 first page: 291 year: 2020
doi: 10.1080/22221751.2020.1722036
4. Detection of unique Ebola virus oligonucleotides using fluorescently-labeled phosphorodiamidate morpholino oligonucleotide probe pairs
Yijia Xiong, Tammie J. McQuistan, James W. Stanek, James E. Summerton, John E. Mata, Thomas C. Squier
Analytical Biochemistry vol: 557 first page: 84 year: 2018
doi: 10.1016/j.ab.2018.07.006
5. Identifying Paucisymptomatic or Asymptomatic and Unrecognized Ebola Virus Disease Among Close Contacts Based on Exposure Risk Assessments and Screening Algorithms
Dehkontee Gayedyu-Dennis, Mosoka P Fallah, Clara Drew, Moses Badio, J S Moses, Tamba Fayiah, Kumblytee Johnson, Eugene T Richardson, Sheri D Weiser, Travis C Porco, Jeffrey N Martin, Michael C Sneller, George W Rutherford, Cavan Reilly, Christina P Lindan, J D Kelly
The Journal of Infectious Diseases vol: 227 issue: 7 first page: 878 year: 2023
doi: 10.1093/infdis/jiac359
6. Outbreak science: recent progress in the detection and response to outbreaks of infectious diseases
Catherine F Houlihan, James AG Whitworth
Clinical Medicine vol: 19 issue: 2 first page: 140 year: 2019
doi: 10.7861/clinmedicine.19-2-140
7. Diagnostic Models for Screening of Periodontitis with Inflammatory Mediators and Microbial Profiles in Saliva
Jungwon Lee, Jun-Beom Lee, Hyun-Young Song, Min Jung Son, Ling Li, In-Chul Rhyu, Yong-Moo Lee, Ki-Tae Koo, Jung-Sub An, Jin Sup Kim, Eunkyung Kim
Diagnostics vol: 10 issue: 10 first page: 820 year: 2020
doi: 10.3390/diagnostics10100820
8. Postmortem Surveillance for Ebola Virus Using OraQuick Ebola Rapid Diagnostic Tests, Eastern Democratic Republic of the Congo, 2019–2020
Daniel Mukadi-Bamuleka, Yibayiri Osee Sanogo, Junior Bulabula-Penge, Maria E. Morales-Betoulle, Patrice Fillon, Patrick Woodruff, Mary J. Choi, Amy Whitesell, Alison M. Todres, Anja De Weggheleire, Anaïs Legand, Jean-Jacques Muyembe-Tamfum, Pierre Formenty, John D. Klena, Joel M. Montgomery, Steve Ahuka-Mundeke
Emerging Infectious Diseases vol: 28 issue: 2 first page: 420 year: 2022
doi: 10.3201/eid2802.210981
9. Operational evaluation of rapid diagnostic testing for Ebola Virus Disease in Guinean laboratories
Amanda VanSteelandt, Josephine Aho, Kristyn Franklin, Jacques Likofata, Jean Baptiste Kamgang, Sakoba Keita, Lamine Koivogui, N’Faly Magassouba, Lise D. Martel, Anicet George Dahourou, Bradley S. Schneider
PLOS ONE vol: 12 issue: 11 first page: e0188047 year: 2017
doi: 10.1371/journal.pone.0188047
10. Deploying RDTs in the DRC Ebola outbreak
Ranu S Dhillon, Devabhaktuni Srikrishna, J Daniel Kelly
The Lancet vol: 391 issue: 10139 first page: 2499 year: 2018
doi: 10.1016/S0140-6736(18)31315-1
11. Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease
John Tembo, Edgar Simulundu, Katendi Changula, Dale Handley, Matthew Gilbert, Moses Chilufya, Danny Asogun, Rashid Ansumana, Nathan Kapata, Francine Ntoumi, Giuseppe Ippolito, Alimuddin Zumla, Matthew Bates
Expert Review of Molecular Diagnostics vol: 19 issue: 4 first page: 325 year: 2019
doi: 10.1080/14737159.2019.1595592